Iodide

Iodide

SCHEMBL3905319

Cc1cccc2c1cc1ccccc1[n+]2C.[I-]

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ACHE known ✓ P22303 9/20 0.42
▸ CYP2A6 P11509 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ CYP1A2 P05177 4/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ ATM Q13315 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MAPT P10636 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2773903 0.98 CYP2A6 (0.48) CYP2A6ALDH1A1ACHECYP1A2HPGD
SCHEMBL9696995 0.89 ALDH1A1 (0.40) CYP2A6ALDH1A1ACHECYP1A2HPGD
SCHEMBL7126850 0.86 ALDH1A1 (0.38) CYP2A6ALDH1A1ACHECYP1A2HPGD
Iodide SCHEMBL30211080 0.80 ATM (0.54) ACHEATMMEN1RAB9AKMT2A
Iodide SCHEMBL11862696 0.80 ATM (0.54) ACHEATMMEN1RAB9AKMT2A
Iodide SCHEMBL8603379 0.80 ATM (0.54) ACHEATMMEN1RAB9AKMT2A
SCHEMBL28257139 0.78 CYP1A2 (0.47) CYP2A6ACHECYP1A2ATMMEN1
Iodide SCHEMBL11862701 0.78 ATM (0.52) ACHEATMMEN1RAB9AKMT2A
SCHEMBL29464772 0.77 ATM (0.56) ACHEATMMEN1RAB9AKMT2A
SCHEMBL278568 0.77 ATM (0.56) ACHEATMMEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531008-B2 Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor L'OREAL S.A. (FR) 2009-05-12 — — US disclosed
US-20070143936-A1 Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor L'OREAL S.A. (FR) 2007-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070143936-A1 Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor KRT18, HKDC1, DSC1 ACHE 1285/4885CYP2A6 1996/4885ALDH1A1 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback